Middle East & Africa Animal Healthcare Market, By Product Type, By Animal Type, By Route of Administration, By Disease Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Middle East & Africa market is expected to show significant growth, owing to adoption of animal healthcare products such as vaccines, hormones and substitutes, and others, and implementation of government regulations to improve animal health in the Middle East and African region. For instance, according to the Animal Disease Act of Africa, it is compulsory to provide guidelines for disease control. According to the regulation, it is mandatory to report notifiable diseases and issue permits for the importation of veterinary biologicals. Furthermore, in some African countries such as Kenya, which has strong centralized veterinary services, it is an offence for individuals who are not registered by the local authority to provide animal healthcare services such as disease diagnosis, treatments, and vaccination. According to the legislation, registered veterinarians or healthcare institutions are allowed to provide livestock health services.

Market Dynamics

Increasing implementation of regulatory guidelines by regional and local authorities present in the Middle East & Africa for overall improvement of animal healthcare is expected to drive the market growth during the forecast period. The implementation of regulatory guidelines is expected to increase awareness among livestock and companion animal owners to provide better facility and care to animals. For instance, in 2018, the Ministry of Climate Change and Environment (MOCCAE) in U.A.E issued new guidelines in Federal Law No. 16 of 2007 for animal welfare and Federal Law No. 18 of 2016. The new animal welfare regulation constitutes of nine articles, which outline animal ownership rules, the healthcare standards of all animal facilities, animal nutrition, and the guidelines for transportation of animals.

Moreover, the regulations for animal vaccination have led to high adoption of animal health products. This is expected to drive the market growth during the forecast period. For instance, in February 2021, the Ministry of Environment Water & Agriculture (MEWA) ministry launched vaccination campaign against foot-and-mouth disease (FMD) in Saudi Arabia. The objective of the campaign was to vaccinate cows and sheep in the country to control and prevent epidemic zoonoses.

Key features of the study:

• This report provides in-depth analysis of the Middle East & Africa animal healthcare market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Middle East & Africa animal healthcare market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Zoetis Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva, Bayer AG, Evonik Industries AG, and Archer Daniels Midland Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Middle East & Africa animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East & Africa animal healthcare market

Detailed Segmentation:

• Middle East & Africa Animal Healthcare Market, By Product Type:
  • Anti-infective
  • Anti-inflammatory
  • Vaccines
    • FMD Vaccines
    • Rabies Vaccines
    • Others
  • Hormones & Substitutes
  • Others
• Middle East & Africa Animal Healthcare Market, By Animal Type:
  • Livestock
    • Bovine
    • Porcine
    • Ovine
    • Poultry
  • Companion
    • Canine
    • Feline
• Middle East & Africa Animal Healthcare Market, By Route of Administration:
  • Oral
  • Parenteral
• Middle East & Africa Animal Healthcare Market, By Disease Indication:
  • Viral diseases
  • Bacterial Diseases
  • Fungal Diseases
  • Others
• Middle East & Africa Animal Healthcare Market, By Distribution Channel:
  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Online Pharmacies
• Middle East & Africa Animal Healthcare Market, By Region:
  • Middle East
    • By Product Type:
    • Anti-infective
    • Anti-inflammatory
    • Vaccines
    • FMD Vaccines
    • Rabies Vaccines
    • Others
    • Hormones & Substitutes
    • Others
    • By Animal Type
    • Livestock
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Companion
    • Canine
    • Feline
    • By Route of Administration:
    • Oral
    • Parenteral
    • By Disease Indication:
    • Viral Diseases
    • Bacterial Diseases
    • Fungal Diseases
    • Others
    • By Distribution Channel:
    • Veterinary Hospitals
    • Veterinary Clinics
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Saudi Arabia
    • Israel
    • UAE
    • Iran
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Anti-infective
    • Anti-inflammatory
    • Vaccines
    • FMD Vaccines
    • Rabies Vaccines
    • Others
    • Hormones & Substitutes
    • Others
    • By Animal Type
    • Livestock
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Companion
    • Canine
    • Feline
    • By Route of Administration:
    • Oral
    • Parenteral
    • By Disease Indication:
    • Viral Diseases
    • Bacterial Diseases
    • Fungal Diseases
    • Others
    • By Distribution Channel:
    • Veterinary Hospitals
    • Veterinary Clinics
    • Retail Pharmacies
    • Online Pharmacies
    • By Country/Region:
    • Egypt
    • Nigeria
    • South Africa
    • Rest of Africa
• Company Profiles
  • Zoetis Inc.*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Elanco
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH
  • Ceva
  • Bayer AG
  • Evonik Industries AG
  • Archer Daniels Midland Company

"*" marked represents similar segmentation in other categories in the respective section.